25 related articles for article (PubMed ID: 14708833)
1. Improvement of oxidative stress status by lipoprotein apheresis in Chinese patients with familial hypercholesterolemia.
Wen J; Dong Q; Liu G; Gao Y; Li XL; Jin JL; Li JJ; Guo YL
J Clin Lab Anal; 2020 May; 34(5):e23161. PubMed ID: 31859412
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment.
Derfler K; Steiner S; Sinzinger H
Wien Klin Wochenschr; 2015 Aug; 127(15-16):655-63. PubMed ID: 26201613
[TBL] [Abstract][Full Text] [Related]
3. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant defense system in familial hypercholesterolemia and the effects of lipoprotein apheresis.
Blaha V; Blaha M; Solichová D; Krčmová LK; Lánská M; Havel E; Vyroubal P; Zadák Z; Žák P; Sobotka L
Atheroscler Suppl; 2017 Nov; 30():159-165. PubMed ID: 29096832
[TBL] [Abstract][Full Text] [Related]
5. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
6. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
[TBL] [Abstract][Full Text] [Related]
7. Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia.
Real JT; Martínez-Hervás S; Tormos MC; Domenech E; Pallardó FV; Sáez-Tormo G; Redon J; Carmena R; Chaves FJ; Ascaso JF; García-García AB
Metabolism; 2010 Feb; 59(2):293-8. PubMed ID: 19800085
[TBL] [Abstract][Full Text] [Related]
8. Effect of lipoprotein apheresis on oxidative stress and antioxidant status in familial hypercholesterolemic patients.
Kurtoglu E; Ugur A; Sait Gonen M; KiSakol G
Int J Artif Organs; 2003 Nov; 26(11):1039-43. PubMed ID: 14708833
[TBL] [Abstract][Full Text] [Related]
9. Review: the oxidant/antioxidant balance during regular low density lipoprotein apheresis.
Schettler V; Methe H; Staschinsky D; Schuff-Werner P; Müller GA; Wieland E
Ther Apher; 1999 Aug; 3(3):219-26. PubMed ID: 10427619
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia.
Vella A; Pineda AA; O'Brien T
Mayo Clin Proc; 2001 Oct; 76(10):1039-46. PubMed ID: 11605688
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein apheresis.
Moriarty PM; Hemphill L
Cardiol Clin; 2015 May; 33(2):197-208. PubMed ID: 25939293
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
